Curis, Inc. Announces Presentations at American Association for Cancer Research Annual Meeting 2009

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation proprietary targeted medicines for cancer treatment, today announced that it will present data on one of its proprietary oncology programs at the upcoming American Association for Cancer Research (AACR) 100th Annual Meeting to be held in Denver, CO at the Colorado Convention Center on April 18-22.

Back to news